Clinical Trial Update: TRPM2 Gene Polymorphism, NLRP3 Inflammasome Expression in Vitiligo Patients

View source ↗

Summary

An update on a study investigating TRPM2 gene polymorphism and NLRP3 inflammasome expression in vitiligo patients, with the trial currently active but not recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vitiligo

Snippet

Sponsor: Aswan University | Conditions: Vitiligo | Status: ACTIVE_NOT_RECRUITING